CANCER PREVENTION AND CONTROL PROGRAM Kerri Winters-Stone, Ph.D., and Pepper Schedin, Ph.D., Program Co-Leaders ABSTRACT Cancer is the most common cause of death in Oregonians, making cancer prevention and control key statewide objectives. Research within the Cancer Prevention and Control (CPC) Program is focused on reducing cancer incidence, morbidity and mortality through innovative approaches that translate knowledge from the bench to at- risk populations and communities. The program strategically focuses on three thematic areas that have high impact across the cancer continuum: 1) prevention and risk reduction, 2) early detection and screening, and 3) cancer survivorship to address health issues from diagnosis to end of life. Researchers in the CPC Program have uncovered novel mechanisms of increased cancer risk including genetic predisposition for UV-induced oxidative stress in melanocytes, nutrient regulation of histone deacetylase activity in prostate and breast, and COX-2- dependent stromal remodeling in breast, developed culturally-tailored education programs to promote cancer screening uptake, have led in the development of national screening recommendations and best practices within the areas of breast, melanoma, colon and lung cancer, defined key mechanisms responsible for debilitating symptoms in cancer survivors such as cachexia, fatigue, and decreased cognition, and have led studies that apply exercise as a countermeasure to reduce inflammation and restore energy balance and musculoskeletal health that are now part of national guidelines. The program is co-led by Kerri Winters-Stone, PhD, and Pepper Schedin, PhD, two senior scientists with complimentary expertise in population-based survivorship research and laboratory- based preclinical chemoprevention, respectively. The 31 members are drawn from nine departments in the School of Medicine and the School of Nursing. Annual total cost funding as of January 2016 amounted to $5,605,762, of which $3,109,502 was from the NCI and $4,718,559 was peer-reviewed. The discoveries made in this program have resulted in 247 publications, of which 30% are intra-programmatic, 12.6% inter-programmatic, and 62.8% inter-institutional collaborations.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA069533-22
Application #
9968130
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
22
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Oregon Health and Science University
Department
Type
DUNS #
096997515
City
Portland
State
OR
Country
United States
Zip Code
97239
Risom, Tyler; Langer, Ellen M; Chapman, Margaret P et al. (2018) Differentiation-state plasticity is a targetable resistance mechanism in basal-like breast cancer. Nat Commun 9:3815
Minnier, Jessica; Pennock, Nathan D; Guo, Qiuchen et al. (2018) RNA-Seq and Expression Arrays: Selection Guidelines for Genome-Wide Expression Profiling. Methods Mol Biol 1783:7-33
Su, Yulong; Pelz, Carl; Huang, Tao et al. (2018) Post-translational modification localizes MYC to the nuclear pore basket to regulate a subset of target genes involved in cellular responses to environmental signals. Genes Dev 32:1398-1419
Gast, Charles E; Silk, Alain D; Zarour, Luai et al. (2018) Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival. Sci Adv 4:eaat7828
Krey, Jocelyn F; Scheffer, Deborah I; Choi, Dongseok et al. (2018) Mass spectrometry quantitation of proteins from small pools of developing auditory and vestibular cells. Sci Data 5:180128
Rozanov, Dmitri V; Rozanov, Nikita D; Chiotti, Kami E et al. (2018) MHC class I loaded ligands from breast cancer cell lines: A potential HLA-I-typed antigen collection. J Proteomics 176:13-23
Winters-Stone, Kerri M; Wood, Lisa J; Stoyles, Sydnee et al. (2018) The Effects of Resistance Exercise on Biomarkers of Breast Cancer Prognosis: A Pooled Analysis of Three Randomized Trials. Cancer Epidemiol Biomarkers Prev 27:146-153
Pennock, Nathan D; Martinson, Holly A; Guo, Qiuchen et al. (2018) Ibuprofen supports macrophage differentiation, T cell recruitment, and tumor suppression in a model of postpartum breast cancer. J Immunother Cancer 6:98
Xu, Li; Gordon, Ryan; Farmer, Rebecca et al. (2018) Precision therapeutic targeting of human cancer cell motility. Nat Commun 9:2454
Chen, Emerson Y; Blanke, Charles D; Haller, Daniel G et al. (2018) A Phase II Study of Celecoxib With Irinotecan, 5-Fluorouracil, and Leucovorin in Patients With Previously Untreated Advanced or Metastatic Colorectal Cancer. Am J Clin Oncol 41:1193-1198

Showing the most recent 10 out of 277 publications